Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis | |
Chen, Qiwen; Dong, Shu; Ding, Zhimin; Zhang, Hao | |
刊名 | INTEGRATIVE CANCER THERAPIES |
2019 | |
卷号 | 18 |
关键词 | colon adenocarcinoma colorectal carcinoma MYC kallikrein-related peptidase KLK6 |
ISSN号 | 1534-7354 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3594270 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Chen, Qiwen,Dong, Shu,Ding, Zhimin,et al. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis[J]. INTEGRATIVE CANCER THERAPIES,2019,18. |
APA | Chen, Qiwen,Dong, Shu,Ding, Zhimin,&Zhang, Hao.(2019).Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis.INTEGRATIVE CANCER THERAPIES,18. |
MLA | Chen, Qiwen,et al."Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis".INTEGRATIVE CANCER THERAPIES 18(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论